These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 3518963)

  • 1. Inhibitory and bactericidal activity of cefmetazole and seven other beta-lactams against different bacterial inocula.
    Esposito S; Galante D; Barba D
    Chemioterapia; 1986 Apr; 5(2):101-4. PubMed ID: 3518963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro microbiological properties of mezlocillin compared with four cephalosporins.
    Esposito S; Galante D; Barba D
    Chemioterapia; 1986 Aug; 5(4):273-7. PubMed ID: 3490314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antibacterial activity of ceftizoxime against gram-negative strains.
    Debbia E; Soro O
    Chemioterapia; 1985 Apr; 4(2):166-9. PubMed ID: 3891115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative activity of ceftizoxime and four other cephalosporins against gram negative bacteria and their sensitivity to beta-lactamases.
    Esposito S; Galante D; Barba D; Pennucci C; Limauro D
    Microbiologica; 1985 Apr; 8(2):197-204. PubMed ID: 3874342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative activity of ceftazidime and four other cephalosporins against gram-negative bacteria and their sensitivity to beta-lactamases.
    Galante D; Esposito S; Barba D; Pennucci C; Limauro D; Scioli C
    Chemioterapia; 1984 Aug; 3(4):250-4. PubMed ID: 6398123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
    Baumgärtner M; Dickgiesser N; Müller S; Wundt W
    Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
    Mascellino MT; Prignano G; Iegri F; Lorenzi A
    Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of six beta-lactams and six quinolones against urinary gram negative bacteria.
    Galante D; Esposito S; Barba D
    Boll Ist Sieroter Milan; 1986; 65(5):361-7. PubMed ID: 3828090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of beta-lactamase stability and antibacterial activity of beta-lactams in beta-lactamase-producing bacteria and respective transconjugants.
    Esposito S; Galante D; Barba D; Pennucci C; Limauro D
    Drugs Exp Clin Res; 1986; 12(4):329-33. PubMed ID: 3522155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
    Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone against gram-negative and gram-positive bacteria: bactericidal and post-antibiotic effect.
    Ravizzola G; Bonfanti C; Savoldi E; Turano A
    Chemioterapia; 1985 Jun; 4(3):204-8. PubMed ID: 3875430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
    Downs JT; Andriole VT
    Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
    Skar AG; Midtvedt T; Dahl O
    NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of ceftazidime on enterobacteria and Pseudomonas producers of beta-lactamases].
    Chabbert YA; Derlot E; Courvalin P
    Pathol Biol (Paris); 1985 Sep; 33(7):758-63. PubMed ID: 3936006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enterobacter cloacae outer membrane permeability to ceftizoxime (FK 749) and five other new cephalosporin derivatives.
    Kojo H; Shigi Y; Nishida M
    J Antibiot (Tokyo); 1980 Mar; 33(3):317-21. PubMed ID: 6247313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carumonam's in-vitro activity against gram-negative bacteria and its stability to their beta-lactamases.
    Raimondi A; Mattina R; Cocuzza CE
    Chemioterapia; 1988 Feb; 7(1):3-9. PubMed ID: 3288365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activity of new cephalosporins against polyresistant bacterial strains].
    De Toffoli A; Fantin B
    Minerva Med; 1983 Mar; 74(9-10):427-31. PubMed ID: 6300736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
    Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T
    Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.